Upstream targets to treat atrial fibrillation

Simple item page
dc.contributor.authorSanders, P.
dc.contributor.authorElliott, A.
dc.contributor.authorLinz, D.
dc.date.issued2017
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityPrashanthan Sanders, Adrian D. Elliott, Dominik Linz
dc.identifier.citationJournal of the American College of Cardiology, 2017; 70(23):2906-2908
dc.identifier.doi10.1016/j.jacc.2017.10.043
dc.identifier.issn0735-1097
dc.identifier.issn1558-3597
dc.identifier.orcidSanders, P. [0000-0003-3803-8429]
dc.identifier.orcidElliott, A. [0000-0002-5951-4239]
dc.identifier.orcidLinz, D. [0000-0003-4893-0824]
dc.identifier.urihttp://hdl.handle.net/2440/110174
dc.language.isoen
dc.publisherElsevier
dc.relation.grantNHMRC
dc.rightsCrown Copyright © 2017 Published by Elsevier on behalf of The American College of Cardiology Foundation. All Rights reserved.
dc.source.urihttps://doi.org/10.1016/j.jacc.2017.10.043
dc.subjectaldosterone
dc.subjectatrial dilation
dc.subjectatrial fibrillation progression
dc.subjectfibrosis
dc.subjectupstream therapy
dc.titleUpstream targets to treat atrial fibrillation
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications